Conduit Pharmaceuticals Inc. (NASDAQ: CDT)
$0.25
+0.0120 ( +5.00% ) 106.1M
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
Market Data
Open
$0.25
Previous close
$0.24
Volume
106.1M
Market cap
$18.54M
Day range
$0.24 - $0.42
52 week range
$0.21 - $12.89
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k/a | 8K-related | 14 | Jul 11, 2024 |
8-k | 8K-related | 14 | Jul 01, 2024 |
4 | Insider transactions | 1 | Jun 11, 2024 |
4 | Insider transactions | 1 | Jun 11, 2024 |
8-k | 8K-related | 14 | May 31, 2024 |
4 | Insider transactions | 1 | May 15, 2024 |
4 | Insider transactions | 1 | May 15, 2024 |
10-q | Quarterly Reports | 71 | May 14, 2024 |
4 | Insider transactions | 1 | Apr 24, 2024 |
4 | Insider transactions | 1 | Apr 24, 2024 |